Market News AIOpen the app

Barclays has increased its price target for Eli Lilly and Company from $1,400 to $1,550.

OpinionRead the original at marketscreener.com
Good for LLY

Barclays raised its target for Eli Lilly from $1,400 to $1,550, showing a more favorable view of its prospects. This is an analyst's opinion, not a reported change in Lilly's sales or products.

LLY · Eli Lilly and Company

AI read · Good for LLY

The AI's read

This is a favorable sign of how Barclays sees Eli Lilly's growth prospects. It is an analyst's view, not a report of changed sales, profits, or products, so the support is limited to that opinion.

Get alerts for LLY

Follow Eli Lilly and Company (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LLY
Free on the App Store and Google Play, or on the web.